<SEC-DOCUMENT>0001415889-24-018276-index.html : 20240626
<SEC-HEADER>0001415889-24-018276.hdr.sgml : 20240626
<ACCEPTANCE-DATETIME>20240626212904
ACCESSION NUMBER:		0001415889-24-018276
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240624
FILED AS OF DATE:		20240626
DATE AS OF CHANGE:		20240626

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Prince Joshua S.
		CENTRAL INDEX KEY:			0001998663
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37761
		FILM NUMBER:		241075085

	MAIL ADDRESS:	
		STREET 1:		C/O VISTAGEN THERAPEUTICS, INC.
		STREET 2:		343 ALLERTON AVE.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vistagen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001411685
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				205093315
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-577-3600

	MAIL ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VistaGen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20110610

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Excaliber Enterprises, Ltd.
		DATE OF NAME CHANGE:	20070906
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-06272024_010600.xml
<TEXT>
Document 1 - file: form4-06272024_010600.html

Document 1 - RAW XML: form4-06272024_010600.xml

</DOCUMENT>
</SEC-DOCUMENT>